Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy

Por Baraf, Herbert SB, Becker, Michael A, Gutierrez-Urena, Sergio R, Treadwell, Edward L, Vazquez-Mellado, Janitzia, Rehrig, Claudia D, Ottery, Faith D, Sundy, John S, Yood, Robert A
Publicado em 2013

Macrophage migration inhibitory factor (MIF) promoter polymorphisms (-794 CATT(5-8) and -173 G>C): association with MIF and TNFα in psoriatic arthritis

Por Morales-Zambrano, Ramsés, Bautista-Herrera, Luis A, la Cruz-Mosso, Ulises De, Villanueva-Quintero, Guadalupe D, Padilla-Gutiérrez, Jorge R, Valle, Yeminia, Parra-Rojas, Isela, Rangel-Villalobos, Héctor, Gutiérrez-Ureña, Sergio R, Muñoz-Valle, José F
Publicado em 2014